OBJECTIVE: To determine if lower urinary tract infection (UTI) is associated with increased proteinuria in pregnancy as measured by the protein: creatinine ratio (PCR). STUDY DESIGN: We performed a prospective study to evaluate the association between UTI and proteinuria in pregnancy. Cases were women with significant bacteriuria on urine culture compared to controls without bacteriuria. Proteinuria as determined by PCR and 24 hour collection was compared. A secondary analysis compared the difference in proteinuria before and after antibiotic treatment compared to controls with two interval measurements. Finally, we assessed if proteinuria elevation varied by causative bacterial organism. RESULTS: We included 76 patients in our analysis, 36 with documented UTI and 40 controls with negative urine cultures. There was no difference in proteinuria when estimated by PCR, mean (SD): 0.201 (0.257) in controls versus 0.194 (0.268) in cases, p¼0.55. We discovered a negative change in proteinuria after therapy, compared to changes in the estimation at two intervals in uninfected women: -0.017 (0.332) in controls and 0.097 (0.223) in cases, p¼0.07. In women with bacteriuria, we found Escherichia coli infection had higher levels of proteinuria when compared to those with mixed microbiology, 0.284 (0.310) versus 0.120 (0.196), p¼0.01; and a greater decrease in proteinuria after therapy, 0.190 (0.288) versus -0.049 (0.204), p¼0.015. CONCLUSION: This study demonstrates that women with a UTI did not have more proteinuria compared to women without a UTI. In addition, we found treatment of a UTI did not lead to a significant reduction in proteinuria. This may vary by causative organism, since we demonstrated Escherichia coli may lead to increased proteinuria compared to other organisms. OBJECTIVE: Evaluate changes in HIV knowledge, stigma, social support, depression, self-efficacy and medication adherence after HIVadapted group prenatal care based on CenteringPregnancy. STUDY DESIGN: All women living with HIV who presented for prenatal care at 30 weeks in the Harris Health System (Houston, TX) between September 2013 and December 2017 elected to follow either group or individual HIV-focused prenatal care. Patients were recruited for the study at their initial prenatal visit. HIV topics including HIV facts, disclosure, medication adherence, safe sex and conception, retention in care, and post-delivery baby testing, were added to the standard CenteringPregnancy curriculum (10 two-hour sessions per pregnancy). Knowledge and attitudes toward factors associated with adherence to HIV treatment regimens (stigma, loneliness, perceived social support and depressive symptoms) were compared on written pre-and post-surveys. Surveys included 58 items derived from validated scales, with Likert and dichotomous responses. McNemar's test, the Wilcoxon sign rank test, and t-tests compared pre-and post-group results. RESULTS: 190 women living with HIV received prenatal care in our clinic during the study period. 93 women (49%) participated in Centering, and 97 (51%) remained in individual prenatal care. 86 women met eligibility criteria for this study. Of these, 72 Centering participants completed pre-tests and 41 completed post-tests.
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